Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy
Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005;52:233-9.
Tissue response and in vivo degradation of selected polyhydroxyacids. polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate- co-3-hydroxyvalerate) (PHB/VA)
Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids. polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3- hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993;27:1135-48.
Sculptra product information [monograph on the Internet]. Berwyn (PA): Dermik Aesthetics; 2004. Available at: http://www.sculptra.com/US/resources/ SculptraPI.pdf
Six simple steps to Sculptra success: Expert advice for incorporating this new filler agent into your practice
Werschler W, Bondar G, Esch P. Six simple steps to Sculptra success: expert advice for incorporating this new filler agent into your practice. Skin Aging 2005;13:56-64.
Questions and answers: ASCDAS 3rd annual meeting. New options in the recognition and treatment of lipoatrophy with volume restoration
Questions and answers: ASCDAS 3rd annual meeting. New options in the recognition and treatment of lipoatrophy with volume restoration. Cosmet Dermatol 2005;18:235-9.